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Abstract
Rutin, a flavonol glycoside isolated from the fruit peels of Malus domestica family Rosaceae, is well known to possess antioxidant
activity. This research was conducted in order to synthesize and characterize rutin derivatives and evaluate their antioxidant
activities. Four derivatives were synthesized namely, Rutin-oxy-5, 7, 4’ acetic acid (2), Rutin -oxy- 5,7, 4’ methyl benzoate amide
(3), 2”, 2”’, 2””-rutinoxymethyl-3-amino-1 -benzo[5,6-a] pyrimidine-4-one (4) and 5”, 5”’, 5””-tri-p-methoxybenzylideneamino-6-
rutinoxy-benzo[5,6-a]-pyrimidin-4(5H)-one (5) . Their structures were elucidated using different spectral data (Mass, IR and 1H,
13C NMR). The antioxidant activities of rutin and its derivatives were evaluated by reducing power, Fe+2 chelating, DPPH∗
and ferric thiocyanate FTC assays. In addition, the results were compared with natural and synthetic antioxidants, such as α-
tocopherol, butylated hydroxytoluene (BHT), butylated hydroxyanisole (BHA) and trolox. Rutin and its derivatives were exhibited
a strong reducing power, chelating activity on Fe2+ and free radical-scavenging. Antioxidant activity of rutin and its derivatives
increased with increased concentrations. Total antioxidant activity of rutin, its derivatives and both standards decreased in the
order of rutin > compound (5) > trolox > compound (2) > BHA > compound (4) > compound (3). This study showed that Rutin and
its derivatives exhibited antioxidant activity in all tests and could be considered as a source of natural and synthetic antioxidants.
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Introduction
Rutin (3,3′,4′,5,7-pentahydroxyflavone-3-rhamnoglucoside:
Figure 1) is a flavonoid of the flavonol-type that is widespread
in the plant kingdom [1]. Rutin has a wide range of phar-
macological properties (e.g., antioxidative activity) that have
been exploited in human medicine and nutrition. Convention-
ally, it is used as an antimicrobial, antifungal, and anti-allergic
agent. However, current research has shown its multi-spectrum
pharmacological benefits for the treatment of various chronic
diseases, such as cancer, diabetes, hypertension, and hyperc-
holesterolemia [2]. Rutin exerts anti-inflammatory effects in
ultraviolet β-irradiated mouse skin by inhibiting the expression
of cyclooxygenase-2 and inducible nitric oxide synthase [3].
Full list of author information is available at the end of the article.
On our going medicinal chemistry research program we
found that pyrimidine derivatives exhibit potent anticancer [4–
12] and antibacterial [13–15] activities. Also, pyrimidine deriva-
tives were found to possess several pharmacological properties,
including antiviral [16], antifungal [17], hypoglycemic [18] and
diuretic [19]activities. As an extension of our studies on the
synthesis of some new biologically active heterocyclic com-
pounds [18, 19], we now wish to report the synthesis of com-
bining form of these two structural features into one molecule
might produce compounds with promising antioxidant effects.
Figure 1 Chemical structure of rutin
Experimental
Plant Material
Apple fruits (Malus domestica Borkh. nom. illeg., cultivar Anna,
family Rosaceae) were collected from the Faculty of Agriculture
eco-station, Faculty of Agriculture Cairo University. and authen-
ticated by the Vegetables and fruits department, Faculty of Agri-
culture, Cairo University. Their peels were cleaned, scraped off,
then dried in shade, in a clean dust free environment at room
temperature for several days and then grinded as powder. The
powder obtained was stored in an air-tight container.
Chemicals and Reagents
All chemicals were purchased from Sigma Chemicals Co., St.
Lious, MO, USA. Precoated TLC plates silica gel 60 GF254 (20
x 20 cm) (E-Merck), polyamide for column chromatography 6,
(Fluka) and sephadex LH-20 for column chromatography (Phar-
mazia)
Apparatus
Rotatory evaporator, Heidolph, (G. Switzerland) was used for
distilling off the different solvents. Melting points were deter-
mined in open capillaries and are uncorrected. 1H- and 13CNMR
spectra were recorded in DMSO-d6 and CD3OD, respectively,
on a JEOL ECA-500 (1H, 500 mHz and 13C, 125 mHz), Na-
tional Research Center, Giza, Egypt. UV-visible spectropho-
tometer, Shimadzu UV (P/N 204-58000) was used for all spec-
trophotometric assays. Melting points were determined on Gal-
lenkamp melting point apparatus and are uncorrected. The in-
frared (IR) spectra were recorded on Shimadzu MR 470 infrared
spectrophotometer using the KBr pellets.
Extraction and isolation
Three hundred and twenty grams of the powdered apple peels
were macerated in 70% aqueous ethanol till exhaustion. The
hydro-ethanolic extracts were concentrated under reduced pres-
sure at a temperature not exceeding 50◦C to yield 47 g dark
brown dried extract. The dried residue was suspended in water
and partitioned successively between water and petroleum ether
(5×50ml), dichloromethane (5×50ml), ethyl acetate (5×50ml)
and n-butanol (5×50ml). The solvents were distilled off to yield
respective fractions of 8.3 g, 6.9 g, 12.4 g and 5.2 g. The ethyl ac-
etate fraction was further fractionated over a column chromatog-
raphy packed with 200 gm polyamide as a stationary phase. The
elution process started with distilled water, followed by gradient
decrease in the polarity by adding methanol, starting with 10%
up to 100% methanol. Fractions were collected each 25 ml and
monitored by TLC on silica gel pre-coated plates using (ethyl
acetate-methanol-water 100:16.5:13.5 v/v/v) as a mobile phase.
The spots were visualized under UV light before and after ex-
posure to ammonia vapors and spraying with aluminum chlo-
ride reagent. Similar fractions were pooled and separately con-
centrated under reduced pressure at a temperature not exceeding
50oC. The water-methanol 7:3 eluted sub-fraction was subjected
to sephadex column chromatography and further eluted with a
stepwise gradient elution of water and methanol which resulted
in the isolation of Compound 1 (31 mg). Its structure was eluci-
dated by spectroscopic means.
Synthesis of rutin derivatives
Synthesis of Rutin-oxy-5, 7, 4’ acetic acid (2)
A mixture of rutin (0.01 mol) and 0.03M NaOH in ethanol/water
(2:8 v/v) was refluxed for 4hr. After cooling 0.03 M chloroacetic
acid was add drop-wise, the solid obtained was recrystallized
from ethanol to give (2 ).
Synthesis of Rutin -oxy- 5,7, 4’ methyl benzoate amide (3)
To a solution of Rutin-oxy-5, 7, 4’ acetic acid (2) (0.01 mol) and
methyl anthranilate (6.93 g, 0.03 mol) in xylene (50 ml), phos-
phorus trichloride (3 ml) was added. The reaction mixture was
heated under reflux for 3–4 h. The crude product was recrystal-
lized from ethanol to give (3).
Synthesis of 2”, 2”’, 2””-rutinoxymethyl-3-amino-1
-benzo[5,6-a]pyrimidine-4-one (4)
A mixture of Rutin -oxy- 5, 7, 4’ methyl benzoate amide (3)
(0.01 mol) and hydrazine hydrate (95 %) (0.15 mol) were dis-
solved in n-butanol (30 ml) and refluxed for 3–5 h. The solvent
was concentrated and the residue was recrystallized from ethanol
to give (4).
Synthesis of 5”, 5”’,
5””-tri-p-methoxybenzylideneamino-6-rutinoxy-benzo [5,
6-a]-pyrimidin-4(5H)-one (5)
A mixture of 2”, 2”’, 2””-rutinoxymethyl-3-amino-1 -benzo[5,6-
a]pyrimidine-4-one (4) (0.01 mol) and p-anisaldehyde (0.03
mol) in n-butanol was refluxed for 4hr. The reaction mixture was
poured onto ice water and the solid obtained was recrystallized
from dioxane to give (5).
Biological Investigations
Determination of antioxidant activity by reducing power
assay
The reducing power of compounds 1-5 were measured according
to the method of Oyaizu [20]. Various concentrations of com-
pounds 1-5 (40–120 µg) in 1 ml of distilled water were mixed
with 2.5 ml of phosphate buffer (0.2 M, pH 7.6) and 2.5-ml
potassium ferricyanide [K3 Fe(CN)6] (1 %, w/v), and then the
mixture was incubated at 50oC for 30 min. Afterward, 2.5 ml of
trichloroacetic acid (10%, w/v) was added to the mixture, which
was then centrifuged at 3,000 rpm for 10 min. Finally, 2.5 ml of
upper-layer solution was mixed with 2.5 ml distilled water and
0.5 ml FeCl3 (0.1 %, w/v), and the absorbance was measured at
700 nm. α- tocopherol, BHA and BHT were used as standard an-
tioxidants. Higher absorbance of the reaction mixture indicated
greater reducing power.
Determination of antioxidant activity by Fe+2 chelating assay
The chelating activity of compounds (1-5) on ferrous ions
(Fe+2) were measured according to the method of Decker and
Welch [21]. Aliquots of 1 ml of different concentrations (0.50,
1.0 and 1.5 mg/ml) of the samples were mixed with 3.7 ml of
deionized water. The mixture was incubated with FeCl2 (2 mM,
0.1 ml) for 10, 30, and 60 min. After incubation, the reaction
was initiated by addition of ferrozine (5 mM and 0.2 ml) for
10 min at room temperature, and then the absorbance was mea-
sured at 562 nm in a spectrophotometer. A lower absorbance
indicates a higher chelating power. The chelating activity of
compounds (1-5) on Fe+2 were compared with that of EDTA at
a level of 0.037 mg/ml. Chelating activity was calculated using
the following formula:
Chelating activity (%) = [1- (Abs of sample/Abs of control) x
100]
Control test was performed without addition of compounds
1-5.
Determination of antioxidant activity by DPPH assay
The free radical-scavenging activity of compounds 1-5 were
measured with 1, 1-diphenyl-2-picrylhydrazil (DPPH•) using
the slightly modified methods of Brand-Williams et al. [22] and
Takashira and Ohtake [23]. Briefly, 6 x10−5 mol/l DPPH• so-
lution in ethanol was prepared and 3.9 ml of this solution was
added to 0.1 ml of the compounds 1-5 (2, 4 and 6 mg/ml) and
trolox solution (0.02, 0.04 and 0.06 mg/ml). The mixture was
shaken vigorously and the decrease in absorbance at 517 nm
was measured at 10, 30, and 60 min. Water (0.1 ml) in place of
compounds 2 and 3 were used as control. The percent inhibition
activity was calculated using the following equation:
Inhibition activity (%) = [(Ao- A1)/ Ao x 100].
Where Ao is the absorbance of the control reaction and A1 is
the absorbance in the presence of compounds 1-5 samples
Determination of antioxidant activity by ferric thiocyanate
FTC assay
The antioxidant activity was determined according to the thio-
cyanate method of Osawa and Namiki [24] with slight modifi-
cations. For the stock solution, 10 mg of compounds 1-5 was
dissolved in 10 ml water. Then, the solution of compounds 1-
5 or standards samples (trolox and BHT) [100 mg/l] in 2.5 ml
of potassium phosphate buffer (0.04 M, pH 7.6) was added to
2.5 ml of linoleic acid emulsion. Fifty-ml linoleic acid emulsion
contained Tween 20 (175 µ), linoleic acid (155 µl), and potas-
sium phosphate buffer (0.04 M, pH 7.6). On the other hand, 5.0
ml of control contained 2.5 ml of linoleic acid emulsion and 2.5
ml of potassium phosphate buffer (0.04 M, pH 7.6). Each solu-
tion was then incubated at 37oC in a glass flask in the dark. At
24 h intervals during incubation, 0.1 ml of this incubation solu-
tion was added to 4.7 ml of 75 % (v/v) ethanol and 0.1 ml of
30 % (w/v) ammonium thiocyanate. Precisely, 3 min after 0.1
ml of 0.02 M FeCl2 in 3.5 % (w/v) HCl was added to the re-
action mixture, the absorbance of the red color was measured
at 500 nm in a spectrophotometer. The solutions without added
compounds 1-5 or standards were used as the control. The inhi-
bition of lipid peroxidation in percentage was calculated by the
following equation.
Inhibition activity (%) = [(Ao- A1)/ Ao x 100].
Where Ao is the absorbance of the control reaction and A1 is
the absorbance in the presence of compounds 1-5 or standards.
Statistical analysis
All the grouped data were statistically evaluated with SPSS/15
software [25]. Hypothesis testing methods included one-way
analysis of variance (ANOVA). P < 0.05 was considered to in-
dicate statistical significance. All the results were expressed as
mean ± SD for six replicates.
Results and discussion
Structure elucidation of the isolated rutin (1)
Yellowish powder obtained from ethyl acetate fraction. The
structure of isolated rutin with melting point of 230-232°C is
presented in Figure 1. IR spectrum of rutin showed that 3365,
3210 (O-H stretching), 1510(C=O groups) and 1390(C-OH vi-
brations); 1HNMR spectrum of rutin displayed the characteris-
tic 3.02-3.6 (m,12H of sugar moieties), 4.3 (d, J=1.15Hz, 1H-
Rham), 0.95 (3H, d,J=6Hz, CH3-Rham), 6.1 (4H,d, J=7.8Hz,
H-1 Glu), 5.3 (1H,d,=2Hz H-6), 6.2 (1H, d, J=2Hz, H-8), 6.7
(1H, d, J =8Hz, H- 5’), 6.99, 7.4, 6.93 (1H, , H-2’, H-6’).
The 13CNMR spectrum showed the presence of specific signals
(aromatic carbon, aliphatic chain and methoxy group) in agree-
ment with the proposed structure of rutin. Also, the 13CNMR
spectrum showed the presence of 161.73 (C-2), 133.8 (C-3),
177.9(C-4), 164.6 (C-5), 104.49(C-6), 168.5(C-7), 94.12 (C-
8), 156.9(C-9), 101.7(C-10), 121.7(C-1’), 116.3(C-2’), 145.6(C-
3’), 148.6(C-4’), 122.1(C-5’), 126.2(C-6’), 99.2(C-1”), 68.8(C-
2”), 76.4(C-3”), 74.6(C-4”), 72.3(C-5”), 71.06(C-6”), 40.1(C-
1”’), 40.00(C-2”’), 39.8(C-3”’), 35.18(C-4”’), 32.8(C-5”’), 24.7
(C-6”” ).
Structure elucidation of Rutin derivatives compounds
(2-5)
Compound 2
Preparation of the target compound Rutin-oxy-5, 7, 4’ acetic
acid (2 ) were achieved by the route depicted in Scheme 1.
The structure of compound (2) was proved on the basis of el-
emental analyses, IR, 1H NMR and 13C NMR spectral data.
The IR spectrum of compound (2) showed bands at 3400 (O-H
stretching), 2916, 2819 (CH2-stretching), 2664 (C-H bond-
ing) and 1701, 1678, 1585, 1541(4C=O groups). 1H NMR
spectrum of compound (2) in (DMSOd6) exhibited signals
at 3.2-3.5(m,12H of sugar moieties), 3.70(d, J=1.15Hz, 1H-
Rham), 1.52(3H,d,J=6Hz, CH3-Rham), 6.3(4H,d, J=7.8Hz, H-1
Glu), 6.31 (1H,d,=2Hz H-6), 7.1 (1H, d, J=2Hz, H-8), 7.4 (1H,
d, J =8Hz, H- 5’), 7.45, 7.46, 7.5 (1H, , H-2’, H-6’), 10.3
(s,1H,carboxylic proton). 13C NMR spectrum of compound (2)
in (DMSOd6) exhibited signals at 156.20 (C-2), 124.84(C-
1’), 114.6(C-2’), 140.42(C-3’), 145.5(C-4’), 127.82(C-5’),
129.79(C-6’), 101.0(C-1”), 48.6(C-2”), 40.7(C-3”), 40.5(C-4”),
40.71(C-5”), 40.34(C-6”), 40.2(C-1”’), 39.9(C-2”’), 39.5(C-
3”’), 35.18(C-4”’), 32.8(C-5”’), 24.7 (C-6””).
Compound 3
The IR spectrum of compound 3 showed bands at 3390 (O-H
stretching) and 1725, 1701, 1690, 1662, 1624, 1600, 1535(7C=O
groups). 1H NMR spectrum of compound 3 in (DMSOd6) ex-
hibited signals at 3.12-3.6, 3.80, 1.04 and 2.46 indicated that
the presence of sugar moieties, 1H-Rham, CH3-Rham, H-1 Glu.
and COCH3, respectively, as well as the absence of carboxylic
protons.13C NMR spectrum of compound 3 in (DMSOd6) ex-
hibited signals at 182.47 (C-2), 123.37(C-1’), 119.47(C-2’),
147.26(C-3’), 140.5(C-4’), 125.4(C-5’), 130.0(C-6’), 95.30(C-
1”), 70.07, 68.86, 56.9(3 methoxy groups), 40.12(C-2”),
39.95(C-3”), 39.7(C-4”), 38.7(C-5”), 35.47(C-6”), 33.65(C-
1”’), 34.60(C-2”’), 30.54(C-3”’), 29.8(C-4”’), 32.8(C-5”’),
18.35 (C-6””).
Compound 4
The IR spectrum of compound 4 showed bands at 3398 (O-H
stretching), 3178, 3274, 3124 cm−1 (NH2) and 1732, 1658,
1690, 1620 (4C=O groups). 1H NMR spectrum of compound 4
in (DMSOd6) exhibited signals at 3.3-3.7, 3.97, 1.13, 6.73 and
6.73, 7.00 indicated that the presence of sugar moieties, 1H-
Rham, CH3-Rham, H-1 Glu. and NH2, respectively, as well as
the absence of COCH3 group.13C NMR spectrum of compound
4 in (DMSOd6) exhibited signals at 200.9 (C-2), 112.6(C-1’),
108.24(C-2’), 135.7(C-3’), 134.9(C-4’), 125.6(C-5’), 116.47(C-
6’), 61.3(C-1”), 51.8(C-2”), 56.3(C-3”), 39.69(C-4”), 29.7(C-
5”), 23.00(C-6”), 21.3(C-1”’), 24.52(C-2”’), 20.44(C-3”’),
19.7(C-4”’), 17.7(C-5”’), 14.01 (C-6””).
Compound 5
The IR spectrum of compound 5 showed bands at 3390 (O-H
stretching), 2923, 2870 (CH2-stretching), 2568 (C-H bonding),
1700, 1635, 1596, 11562(4C=O groups) and 1350 (C-OH vibra-
tions) and indicated that the absence of NH2 group. 1H NMR
spectrum of compound 5 in (DMSOd6) exhibited signals at 3.4-
3.7, 4.1, 1.2 and 6.98 indicated that the presence of sugar moi-
eties, 1H-Rham, CH3-Rham. and H-1 Glu. as well as the ab-
sence of NH2 signal, respectively. Also, 1H NMR spectrum in-
dicated that the absence of signal at 6.2 [s, 1H, N=CH, proton].
13C NMR spectrum of compound 5 in (DMSOd6) exhibited
signals at 176.03 (C-2), 120.9(C-1’), 96.6(C-2’), 143.7(C-3’),
130.5(C-4’), 116.9(C-5’), 115.8(C-6’), 71.9(C-1”), 56.17(C-2”),
53.9(C-3”), 40.15(C-4”), 39.98(C-5”), 39.82(C-6”), 27.18(C-
1”’), 24.52(C-2”’), 23.5 (C-5”) , 22.65 (C-5”’) and 20.7(3C-5”’)
indicated that the presence of 3 double bond at [N=CH], 18.98
(C-6””).
Antioxidant activities
It is well known from the literature that the tested rutin ant it’s
derivatives exhibit a wide range of biological activities. So, it
was of interest to design new compounds containing both these
biologically active phenolic moieties and to study their antioxi-
dant activities.
Figure 2 shows the reducing power of compounds 1-5. The
reducing power of compounds 1-5 increased with increasing
concentration. Based on a comparison of the absorbance at 700
nm, the reducing power of compounds 1 and 5 at a concentration
of 40 µg/ml were nearly similar to that of BHT. This indicates
that compounds 1 and 5 were electron donors and could also
react with free radicals, converting them to more stable prod-
ucts and terminate the radical chain reaction. Also, 120 µg/ml
compounds 1-5 are the best concentration which exhibits the
most reducing power. In the reducing power assay, the pres-
ence of reductants (antioxidants) resulted in the reduction of
the Fe+3/ferricyanide complex to the ferrous form (Fe+2) ta-
ble 1. The amount of Fe+2complex can therefore be monitored
by measuring the formation of Perl’s Prussian Blue at 700 nm.
The reducing power of compounds 1-5 and both standards de-
creased in the order of compound 1> compound 5> BHT > com-
pound 2 > compound 4 > α-tocopherol > BHA> compound 3.
Table 2 shows the chelating effect of compounds 1-5. All sam-
ples at 1.50 mg/ml concentration showed the best chelating ef-
fect 48.87, 33.5, 20.8, 34.3 and 43.89% on ferrous ions at an in-
cubation time of 60 min, respectively. The chelating activity of
samples increased with increasing incubation times with FeCl2.
However, the chelating activity of compounds 2 of 1.25 mg/ml
(30 %) was lower than EDTA at 0.037 mg/ml (43.67 %) for
an incubation time of 90 min. This indicates that the chelation
property of the compounds 1-5 on Fe+2 ions may afford protec-
tion against oxidative damage. The results in table 2, indicated
that a significant property of compounds 1-5 is its capability for
blocking the oxidative activity of systems with transition metal
ion (Fe+2/Fe+3) that play an essential role in the formation of
reactive oxygen species in Fenton’s reactions.
The DPPH∗ radical-scavenging effects of compounds 1-5
are presented in Figure. 2 and showed appreciable free radical-
scavenging activities. The free radical-scavenging activity of
compounds 1-5 were compared to trolox, as a synthetic an-
tioxidant. Compounds 1-5 of 6 mg/ml had the highest radical-
scavenging activity when compared with 0.06 mg/ml trolox. The
effects of 100 mg/l of compounds 1-5 on peroxidation of linoleic
acid emulsion are shown in Figure. 2.
Compound 1(0.06mg/ml) showed higher antioxidant activity
when compared to trolox, BHA, and BHT. Total antioxidant ac-
tivity of compounds 1-5 and both standards decreased in the
order of compound 1> compound 5> trolox > compound 4 >
compound 2 > compound 3. Free radicals are known to be a ma-
jor factor in biological damages, and DPPH• has been used to
evaluate the free radical-scavenging activity of natural antiox-
idants [26]. DPPH•, which is a molecule containing a stable
free radical with a purple color, changes into a stable compound
with a yellow color by reacting with an antioxidant which can
donate an electron to DPPH•. In such case, the purple color
typical of the free DPPH• radical decays, a change which can
be followed either spectrophotometrically (517 nm). The pro-
ton radical-scavenging action is known as an important mecha-
nism of antioxidation. 1, 1-Diphenyl-2-picrylhydrazil (DPPH•)
is used as a free radical to evaluate the antioxidative activity of
some natural sources [27]. The DPPH• radical-scavenging ef-
fects of compounds 1-5 are presented in Fig. 3. From these re-
sults, it can be stated that compounds 1 and 5 have the ability
to scavenge free radicals and could serve as a strong free radi-
cal inhibitor or scavenger according to trolox. Many attempts at
explaining the structure–activity relationships of some phenolic
compounds have been reported in the literature. It has been re-
ported that the antioxidant activity of phenolic compounds may
result from the neutralization of free radicals initiating oxidation
processes, or from the termination of radical chain reactions, due
to their hydrogen donating ability [28]. It is also known that the
antioxidant activity of phenolic compounds is closely associated
with their structures, such as substitutions on the aromatic ring
and side chain structure. Their accessibility to the radical cen-
ter of DPPH• could also influence the order of the antioxidant
power. Free radical scavenging activity of phenolic compounds
is believed to be influenced by the number and position of phe-
nolic hydrogen in their molecules [29]. It is also proposed that
the higher antioxidant activity of compounds 1-5 is related to the
presence of hydroxyl groups [30].








Compounds 40 ug/ml 60 ug/ml 80 ug/ml 100 ug/ml 120 ug/ml
1 0.43±0.02Aa 0.45±0.02Aa 0.54±0.01A 0.62±0.02A 0.76±0.02A
2 0.28±0.01Ba 0.32±0.02B 0.42±0.04Ba 0.50±0.03B 0.51±0.03B
3 0.19±0.03Ca 0.21±0.01Ca 0.32±0.02Cb 0.36±0.02Cb 0.40±0.02C
4 0.26±0.02B 0.35±0.02Ba 0.37±0.01Ca 0.44±0.04Bb 0.48±0.04Bb
5 0.46±0.01A 0.53±0.03Aa 0.58±0.03Aa 0.64±0.03Ab 0.69±0.02Ab
α- tocopherol 0.33±0.05Ba 0.34±0.01Ba 0.39±0.02C 0.46±0.02Bb 0.45±0.01Cb
BHT 0.45±0.03Aa 0.48 ±0.02Aa 0.46±0.04Ba 0.50±0.01Bb 0.53±0.04Bb
BHA 0.25±0.04Ba 0.27±0.03Ca 0.34±0.02Cb 0.39±0.01Cb 0.41±0.02C
Values are given as mean ± SD for six replicates
Data followed by the same letter are not significantly different atP ≤ 0.05. Small letters are used for comparison between the means within thecolumns.
Capital letters are used to compare means within the rows.
Figure 2 Rationalized formation of compounds 1-5













Compounds 10 min. 30 min. 60 min. 90 min. 120 min.
1 15.50 ±1.5A 30.98 ±1.5A 48.87 ±3.18A 53.30 ±2.97Aa 53.3 ±4.3Aa
2 10.38 ±0.98B 25.48 ±2.45B 33.50 ±2.04Ba 36.09 ±2.77a 36.99 ±3.25a
3 6.72 ±0.67 12.76 ±2.14 20.85 ±3.27a 22.11 ±3.00a 23.65 ±2.61a
4 9.86 ±0.9B 21.50 ±2.71B 34.30 ±3.08B 44.28 ±4.22a 46.90 ±2.59a
5 18.11 ± 2.06A 29.96 ±2.76A 43.89 ±4.07A 49.11 ±3.80Aa 50.25 ±3.97Aa
Values are given as mean ± SD for six replicates
Data followed by the same letter are not significantly different atP ≤ 0.05. Small letters are used for comparison between the means within thecolumns.
Capital letters are used to compare means within the rows.
Conclusion
In conclusion, rutin when combining with quinazoline deriva-
tives exhibited promising antioxidant activity. More studies are 
needed to prove their medicinal and biological importance which 
may pave the way for possible therapeutic applications.
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